Adma Biologics (ADMA) Other Operating Expenses (2011 - 2025)

Adma Biologics' Other Operating Expenses history runs 13 years deep, the most recent figure standing at $1.2 million for Q4 2025.

• Quarterly Other Operating Expenses fell 9.6% year-over-year to $1.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.0 million (up 7.53% YoY) and the FY2025 annual result came in at $5.0 million, up 7.49% from the prior year.
• Other Operating Expenses was $1.2 million for Q4 2025 at Adma Biologics, down from $1.3 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $5.3 million in Q4 2022 and bottomed at $646000.0 in Q3 2023.
• A 5-year average of $2.3 million and a median of $1.4 million in 2023 frame the typical range for Other Operating Expenses.
• Annual changes were most pronounced in 2021 — Other Operating Expenses surged 110.58% — and 2023, when it tumbled 87.18%.
• Adma Biologics' Other Operating Expenses stood at $4.3 million in 2021, then increased by 23.16% to $5.3 million in 2022, then plunged by 83.44% to $872000.0 in 2023, then jumped by 49.31% to $1.3 million in 2024, then slipped by 9.6% to $1.2 million in 2025.
• Business Quant data shows ADMA's Other Operating Expenses at $1.2 million in Q4 2025, $1.3 million in Q3 2025, and $1.2 million in Q2 2025.